Abstract
Background Heparin induced thrombocytopenia type II (HIT type II) is well defined thrombophylic and immunological complication due to heparin therapy, Witch occurs in 1-3% treated patients. In around 50% of the patients with HIT type II have developed serious thrombotic arterial and venous complications. It has a special place in cardiac surgery, regarding standard use of heparin. In patients with HIT type II is contraindicated continuation of heparin therapy including use of low molecular heparin. Alternative drugs should be used as danaparoid sodium, lepirudin , argatroban.
Highlights
Heparin induced thrombocytopenia type II (HIT type II) is well defined thrombophylic and immunological complication due to heparin therapy, Witch occurs in 1-3% treated patients
It has a special place in cardiac surgery, regarding standard use of heparin
The diagnosis and treatment of HIT type II needs to be considered on an individual basis, because of the variable presentation and severity of the syndrome
Summary
Our experience in three coronary patients with heparin induced thrombocytopenia type II, platelets. A Mikić1*, M Velinović, M Vraneš, R Karan, N Savić, B Nikolić, V Jovičić, M Čubrilo, N Aleksić, M Šamanović. From 23rd World Congress of the World Society of Cardio-Thoracic Surgeons Split, Croatia. From 23rd World Congress of the World Society of Cardio-Thoracic Surgeons Split, Croatia. 12-15 September 2013
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
